Introduction：Basic information about CAS 352431-51-7|17β-Dihydroequilin 3-sulfate-2,4,16,16-d4 sodium, including its chemical name, molecular formula, synonyms, physicochemical properties, and safety information, etc.
| Common Name | 17β-Dihydroequilin 3-sulfate-2,4,16,16-d4 sodium |
|---|
| CAS Number | 352431-51-7 | Molecular Weight | 376.44 |
|---|
| Density | / | Boiling Point | / |
|---|
| Molecular Formula | C18H17D4NaO5S | Melting Point | / |
|---|
| MSDS | / | Flash Point | / |
|---|
Names
| Name | sodium 17beta-dihydroequilin-2,4,16,16-d4 3-sulfate |
|---|
BiologicalActivity
| Description | 17β-Dihydroequilin 3-sulfate-2,4,16,16-d4 (sodium) is the deuterium labeled 17β-Dihydroequilin 3-sulfate-2,4,16,16. |
|---|
| Related Catalog | Signaling Pathways >>Others >>Others |
|---|
| In Vitro | Stable heavy isotopes of hydrogen, carbon, and other elements have been incorporated into drug molecules, largely as tracers for quantitation during the drug development process. Deuteration has gained attention because of its potential to affect the pharmacokinetic and metabolic profiles of drugs[1]. |
|---|
| References | [1]. Russak EM, et al. Impact of Deuterium Substitution on the Pharmacokinetics of Pharmaceuticals. Ann Pharmacother. 2019;53(2):211-216. |
|---|
Chemical & Physical Properties
| Molecular Formula | C18H17D4NaO5S |
|---|
| Molecular Weight | 376.44 |
|---|
| Exact Mass | 376.12600 |
|---|
| PSA | 95.04000 |
|---|
| LogP | 3.74350 |
|---|
| InChIKey | CZFNZYFVJFYZML-NRRXTGDUSA-M |
|---|
| SMILES | CC12CCC3C(=CCc4cc(OS(=O)(=O)[O-])ccc43)C1CCC2O.[Na+] |
|---|
